Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) is a chronic relapsing condition with unknown etiology. To gain insight into the molecular processes underlying the disease, we examined biomarkers in blood samples collected prior to symptom onset.

[1]  S. Rantapää-Dahlqvist,et al.  Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study. , 2020, Journal of autoimmunity.

[2]  Kang Hyun Kim,et al.  Immunopathogenesis of ANCA-Associated Vasculitis , 2020, International journal of molecular sciences.

[3]  A. Vaglio,et al.  Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome , 2020, Clinical kidney journal.

[4]  G. Brady,et al.  Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism. , 2020, Rheumatology.

[5]  K. Hosomi,et al.  Diversity of energy metabolism in immune responses regulated by micro-organisms and dietary nutrition , 2020, International immunology.

[6]  A. Alexeyenko,et al.  Protein profiling and network enrichment analysis in individuals before and after the onset of rheumatoid arthritis , 2019, Arthritis Research & Therapy.

[7]  M. Gallieni,et al.  Update on ANCA-associated vasculitis: from biomarkers to therapy , 2019, Journal of Nephrology.

[8]  S. Verleden,et al.  The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease , 2019, EBioMedicine.

[9]  Zhenghui Liu,et al.  Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis. , 2019, Blood advances.

[10]  J. C. Jennette,et al.  ANCA Glomerulonephritis and Vasculitis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[11]  A. Peters,et al.  Tissue proteases convert CCL23 into potent monocyte chemoattractants in patients with chronic rhinosinusitis. , 2016, The Journal of allergy and clinical immunology.

[12]  J. Ernerudh,et al.  Increase in Th17-associated CCL20 and decrease in Th2-associated CCL22 plasma chemokines in active ANCA-associated vasculitis , 2015, Scandinavian journal of rheumatology.

[13]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[14]  S. Ricardo,et al.  Macrophages and CSF-1 , 2013, Organogenesis.

[15]  S. Holdsworth,et al.  Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. , 2013, Cellular immunology.

[16]  Jianchun Chen,et al.  CSF-1 signaling mediates recovery from acute kidney injury. , 2012, The Journal of clinical investigation.

[17]  Y. Pawitan,et al.  Network enrichment analysis: extension of gene-set enrichment analysis to gene networks , 2012, BMC Bioinformatics.

[18]  Panos Deloukas,et al.  Genetically distinct subsets within ANCA-associated vasculitis. , 2012, The New England journal of medicine.

[19]  Gary D. Bader,et al.  Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..

[20]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[21]  E. Campbell,et al.  Metabolic Shifts in Immunity and Inflammation , 2010, The Journal of Immunology.

[22]  M. Fasshauer,et al.  Fibroblast Growth Factor 19 Serum Levels: Relation to Renal Function and Metabolic Parameters , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[23]  Y. Shoenfeld,et al.  Infection and vasculitis , 2008, Rheumatology.

[24]  N. Nakahata.  Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. , 2008, Pharmacology & therapeutics.

[25]  D. Scott,et al.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies , 2006, Annals of the rheumatic diseases.

[26]  A. Thomson,et al.  Flt3 ligand (FL) and its influence on immune reactivity. , 2000, Cytokine.

[27]  D. Carbone,et al.  Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. , 1999, Journal of immunology.

[28]  R. Gentz,et al.  Molecular and Functional Characterization of  Two Novel Human C-C Chemokines as Inhibitors of  Two Distinct Classes of Myeloid Progenitors , 1997, The Journal of experimental medicine.

[29]  M. Baggiolini,et al.  Materials and Methods Brief Definitive Report Neutrophil-activating Properties of the Melanoma Growth-stimulatory Activity Fura-2/am and Bsa Were Purchased from Fluka Ag, Buchs, Switzerland . Human Recombinant Nap-1/il-8 Was Obtained from The , 2022 .

[30]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[31]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[32]  R. Kizek,et al.  Matrix metalloproteinases. , 2010, Current medicinal chemistry.

[33]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[34]  Susumu Goto,et al.  The KEGG databases at GenomeNet , 2002, Nucleic Acids Res..

[35]  E. Rosen,et al.  Regulation of angiogenesis by scatter factor. , 1997, EXS.

[36]  M. Kendall.  Statistical Methods for Research Workers , 1937, Nature.